Friday, May 1, 2026

Tesla Ditches U.S. for China in Robotaxi Trials

According to China Daily, on May 8th,...

North Korea Test-Fires New Surface-To-Air Missile Escalating Global Tension Through High-Altitude Interception Capability

North Korea successfully test-fired a new anti-aircraft missile system, potentially countering the U.S. THAAD system, analysts suggest.

ENERGY EXTORTION: Trump Threatens South Korea With “Favorite” Tariffs To Force Sales Of Ancient Coal

Trump promotes coal exports during a White House event, highlighting tariff negotiations with South Korea and energy production achievements.

Tag: Alzheimer's

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

MSD Korea Announced at Bio Korea 2026 that Korea is a Crucial Hub for Global Innovation

Korea is now a key innovation hub for MSD, focusing on neuroscience and clinical research collaborations, with significant R&D investments.

Significant Weight Loss Substantially Increases Mortality Risk in Dementia Patients

A study finds dementia patients with significant weight loss face higher mortality risks, while stable weight or moderate gain lowers risks.

Unlocking Alzheimer’s: The Surprising Role of Tau Protein in Cell Division Revealed

POSTECH researchers reveal tau protein's new role in DNA interaction, impacting Alzheimer's, infertility, and congenital disorders.

Neurophet AQUA AD Plus: Revolutionizing Alzheimer’s Diagnosis with AI at AD/PD 2026

Neurophet showcased its AI solutions for Alzheimer's at AD/PD 2026, aiming to foster collaborations in treatment development.

Korean Medical AI Lands at the University of Washington: Neurofit Signs U.S. Deal for Brain MRI + PET Analysis Tools

Neurofit signs a contract to supply AI medical solutions to the University of Washington, marking its U.S. market entry and expansion.

How Neurophet AQUA is Transforming Dementia Diagnosis in South Korea: Key MOU Insights

Neurophet partners with Eisai Korea to enhance dementia screening and diagnostics using AI-based software, Neurophet AQUA.

Early-Onset Dementia: The Growing Need for Early Detection and Prevention

Early-onset dementia affects those under 65, with symptoms requiring early recognition and treatment for better outcomes.

Study Reveals: Taking Statins for 3 Years Can Slash Dementia Risk by 63%!

A study reveals statins can reduce dementia risk by 63%, especially in diabetic patients, highlighting their protective benefits.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.